Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cells
about
Intracellular pathways triggered by the selective FLT-1-agonist placental growth factor in vascular smooth muscle cells exposed to hypoxiaSuppression of JAK2/STAT3 signaling reduces end-to-end arterial anastomosis induced cell proliferation in common carotid arteries of ratsContribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis.Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosisClinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancerStat3-dependent acute Rantes production in vascular smooth muscle cells modulates inflammation following arterial injury in mice.Retinol binding protein 4 promotes hyperinsulinism‑induced proliferation of rat aortic smooth muscle cells.Monocyte chemoattractant protein-1-deficiency impairs the expression of IL-6, IL-1β and G-CSF after transient focal ischemia in miceFree fatty acid palmitate impairs the vitality and function of cultured human bladder smooth muscle cells.Small-nucleic-acid-based therapeutic strategy targeting the transcription factors regulating the vascular inflammation, remodeling and fibrosis in atherosclerosisThe Interleukin-6 inflammation pathway from cholesterol to aging--role of statins, bisphosphonates and plant polyphenols in aging and age-related diseasesUpdate on the Pathophysiological Role of Intracellular Signaling Pathways in Atherosclerotic Plaques and Ischemic MyocardiumAngiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient miceAdipocytokine levels mark endothelial function in normotensive individuals.Macrophage plasticity and the role of inflammation in skeletal muscle repairRheumatoid Arthritis Pharmacotherapies: Do They Have Anti-Atherosclerotic Activity?Fluorofenidone protects against renal fibrosis by inhibiting STAT3 tyrosine phosphorylation.In vivo treatment of rat arterial adventitia with interleukin‑1β induces intimal proliferation via the JAK2/STAT3 signaling pathwayJAK kinases promote invasiveness in VHL-mediated renal cell carcinoma by a suppressor of cytokine signaling-regulated, HIF-independent mechanism.SOCS1 gene promoter methylation status is associated with in-stent restenosis after percutaneous coronary intervention.Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the JAK/STAT signaling activation.IL-6 promotes epithelial-to-mesenchymal transition of human peritoneal mesothelial cells possibly through the JAK2/STAT3 signaling pathway.Inhibited proliferation of human umbilical artery smooth muscle cells by xanthinol nicotinate.Involvement of RBP4 in hyperinsulinism-induced vascular smooth muscle cell proliferation.
P2860
Q28572517-EF0C4C69-A5FB-4E1A-93F5-31B9E22AA9C3Q28574197-6B6F1983-8459-4087-8A88-881FF2BD502CQ30318502-6105BE48-7291-4355-B7C5-76D2D17C9419Q30319434-D462CDB4-7E71-497F-B704-DD7E59ED5407Q30433361-C0CAA272-B158-4AE9-8752-D15E501871D2Q33448971-FBAEB2E5-BC43-42FE-8D0C-8A4A04809AFDQ33559676-97A128EA-6795-4878-B821-2AA3B2FFA476Q33608692-CBA4DBAC-650F-4CDC-B0DC-B579777322D5Q34059585-48E0E5C5-D71F-4A8C-BB79-566BB29B5332Q34342527-D3D5912A-3F9B-42DE-BF14-7E9037FF3301Q35723980-F5D0B43C-E07A-4F6C-B782-89215FFF3422Q35738921-9475EFA8-CDB6-4532-88A0-C8349FB19895Q36055827-A85C82D5-E259-435E-AF7E-819496B2F548Q36377589-BC76D124-A623-456A-8923-176385D66944Q36412596-1F5EC146-4BCF-4474-A9F5-7C723B3E8A3CQ36610415-3E07CDF4-8F86-42F0-A10F-D6BF0354D8D9Q38794852-F8A59972-1866-4B30-AC29-746572BC779EQ38868643-8DA1E33A-1B40-46E1-ADB7-2B5EF3B09130Q39408259-318C685C-279A-471F-AD3C-9F38EA078B5BQ40075798-F14FE562-2013-4260-AD4D-07465D8C40AFQ41343821-B0EDCD50-71BC-487F-A2D2-EC4791027E77Q43106827-2A457C08-2637-48B8-B0FC-508918B38F1AQ50657726-B4E5C174-D73B-4B06-A06A-2BBCF126FBBCQ53224673-A53E5B19-418C-4F0D-BCB6-CBB2980B287FQ54348266-D2B2A612-4D6A-44CE-AEB1-89D2ABFCB838
P2860
Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cells
description
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2004
@ast
scientific journal article
@en
vedecký článok (publikovaný 2004/07/01)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/07/01)
@nl
наукова стаття, опублікована в липні 2004
@uk
مقالة علمية (نشرت في يوليو 2004)
@ar
name
Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cells
@ast
Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cells
@en
Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cells
@nl
type
label
Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cells
@ast
Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cells
@en
Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cells
@nl
prefLabel
Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cells
@ast
Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cells
@en
Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cells
@nl
P2093
P2860
P356
P1476
Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cells
@en
P2093
Andrew Kahn
Naijie Jing
Richard J Johnson
Ryuji Ohashi
Susumu Watanabe
Takahiko Nakagawa
P2860
P304
P356
10.1159/000079706
P50
P577
2004-07-09T00:00:00Z